Book of Abstracts - Ruhr-Universität Bochum
Book of Abstracts - Ruhr-Universität Bochum
Book of Abstracts - Ruhr-Universität Bochum
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
OP-26<br />
ISBOMC `10 5.7 – 9.7. 2010 <strong>Ruhr</strong>-<strong>Universität</strong> <strong>Bochum</strong><br />
CO Releasing Properties <strong>of</strong> cis-trans-[Re II (CO)2Br2L2] n Complexes: A Feature<br />
Modulated by Ligand Variation for a True Chance at Medicinal Applications.<br />
Fabio Zobi* a and Alois Degonda a<br />
a University <strong>of</strong> Zürich, Institute <strong>of</strong> Inorganic Chemistry, Winterthurerstr. 190, CH-8057, Zürich,<br />
Switzerland. E-mail: fzobi@aci.uzh.ch<br />
In recent years carbon monoxide (CO) has been acknowledged as a fundamental small-molecule<br />
messenger in humans. 1 The tissue specific distribution <strong>of</strong> heme oxigenases and their action-derived<br />
CO have been linked to several effects. For example, carbon monoxide acts as a signaling molecule in<br />
the inducible defensive system against stressful stimuli. 1 It plays a fundamental role in the circulatory<br />
system by improving vasorelaxation and cardiac blood supply and it suppresses arteriosclerotic lesions<br />
associated with chronic graft rejection. 1,2 As the importance <strong>of</strong> CO is been increasingly recognized,<br />
there is a steadily growing interest in the in pharmacological and medicinal applications <strong>of</strong> CO. Direct<br />
inhalation <strong>of</strong> carbon monoxide has been viewed as a novel therapeutic approach but reports on<br />
tolerance to CO exposure are contradictory.<br />
An alternative approach to the administration <strong>of</strong> carbon monoxide is the use <strong>of</strong> CO-releasing<br />
molecules (CORMs). An obvious choice for CORMs are transition metal carbonyl complexes with<br />
one or more CO ligands. Several complexes have been evaluated to date, but the pioneering work <strong>of</strong><br />
Motterlini and Mann has resulted in the discovery <strong>of</strong> the fac-[RuCl(glycinato)(CO)3] complex<br />
(CORM-3) as the most promising compound for the CO release in vivo. 3<br />
In here we show that complexes <strong>of</strong> the type cis-trans-[Re II (CO)2Br2L2] n (where L = monodentate<br />
ligand) 4 act as CO-releasing molecules and that under physiologically relevant conditions the rate <strong>of</strong><br />
CO release is comparable to that <strong>of</strong> CORM-3. The complexes represent a first example <strong>of</strong> metal-based<br />
CORMs in which the central metal ion is not found in a d 6 or d 8 configuration. The open shell d 5<br />
configuration <strong>of</strong> the Re system herein described represents an advantage over the more robust d 6 or d 8<br />
systems for which physical stimuli (e.g. UV radiation) are <strong>of</strong>ten needed in order to elicit dissociation<br />
<strong>of</strong> carbon monoxide from the metal core. The rate <strong>of</strong> CO release <strong>of</strong> cis-trans-[Re II (CO)2Br2L2] n<br />
complexes is pH dependent and can be modulated by ligand variation. These features <strong>of</strong>fer a true<br />
chance for the application <strong>of</strong> these molecules in medicinal chemistry.<br />
References<br />
1. Wu, L.; Wang, R., Pharmacol. Rev. 2005, 57, 585-630.<br />
2. Otterbein, L. E.; Zuckerbraun, B. S.; Haga, M.; Liu, F.; Song, R. P.; Usheva, A.; Stachulak, C.;<br />
Bodyak, N.; Smith, R. N.; Csizmadia, E.; Tyagi, S.; Akamatsu, Y.; Flavell, R. J.; Billiar, T. R.; Tzeng,<br />
E.; Bach, F. H.; Choi, A. M. K.; Soares, M. P., Nature Med. 2003, 9, 183-190.<br />
3. Foresti, R.; Bani-Hani, M. G.; Motterlini, R., Intensive Care Med. 2008, 34, 649-658.<br />
4. Zobi, F.; Kromer, L.; Spingler, B.; Alberto, R., Inorg. Chem. 2009, 48, 8965-8970.<br />
42